Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PLENVU | Salix Pharmaceuticals | N-209381 RX | 2018-05-04 | 1 products, RLD, RS |
MOVIPREP | Salix Pharmaceuticals | N-021881 RX | 2006-08-02 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ASCOR | McGuff Pharmaceuticals | N-209112 RX | 2017-10-02 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
acetaminophen, ascorbic acid, chlorpheniramine maleate | Export only | 2024-05-08 |
anubis barcelona | OTC monograph final | 2023-09-01 |
aoa0 snail ginseng cream | C200263 | 2025-01-08 |
aoao snail ginseng anti wrinkle age essence box set | C200263 | 2024-09-21 |
aoao snail ginseng anti wrinkle serum | C200263 | 2024-09-23 |
aoao snaili ginseng anti wrinkle cream | C200263 | 2024-09-26 |
aoao snow bieach intensive for face and body | C200263 | 2024-10-18 |
aoao whitening cream | C200263 | 2024-10-13 |
aromacura shower filter | unapproved drug other | 2021-01-05 |
aronamin gold | unapproved drug other | 2018-12-12 |
Expiration | Code | ||
---|---|---|---|
ASCORBIC ACID, ASCOR, MCGUFF | |||
2024-10-02 | ODE-160 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Plenvu, Salix | |||
8999313 | 2033-09-10 | DP | |
9326969 | 2033-09-10 | U-2310 | |
9707297 | 2033-09-10 | DP | |
10016504 | 2033-09-10 | DP | |
10918723 | 2033-09-10 | U-2310 | |
9592252 | 2032-08-11 | DP | U-2310 |
10646512 | 2032-03-25 | DP | |
10780112 | 2032-03-09 | DP | |
10792306 | 2032-03-09 | DP | U-2310 |
11529368 | 2032-03-09 | DP | U-2310 |
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Moviprep, Salix Pharms | |||
7169381 | 2024-09-01 | DS, DP | |
7658914 | 2024-09-01 | DS, DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatitis | D006505 | — | K75.9 | 1 | — | — | 1 | — | 2 |
Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | — | — | 1 | — | 2 |
Hepatitis c | D006526 | — | B19.2 | — | — | — | 1 | — | 1 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | 1 | — | 1 |
Chronic hepatitis | D006521 | — | K73.9 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | — | 1 | 2 | — | — | 3 |
Colonic neoplasms | D003110 | — | C18 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 7 | 11 | — | — | 4 | 20 |
Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 7 | — | — | 3 | 18 |
Preleukemia | D011289 | — | — | 7 | 9 | — | — | 3 | 17 |
Multiple myeloma | D009101 | — | C90.0 | 7 | 11 | — | — | 3 | 17 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 2 | 1 | — | — | 14 | 17 |
Myeloid leukemia | D007951 | — | C92 | 9 | 8 | — | — | 1 | 16 |
Plasma cell neoplasms | D054219 | — | — | 7 | 9 | — | — | 1 | 13 |
Non-small-cell lung carcinoma | D002289 | — | — | 7 | 7 | — | — | 2 | 13 |
Obstructive lung diseases | D008173 | — | — | 2 | 1 | — | — | 8 | 11 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 4 | — | — | 7 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 4 | — | — | — | 2 | 6 |
Sclerosis | D012598 | — | — | 3 | — | — | — | 3 | 6 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | — | — | — | 3 | 5 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | — | — | — | 4 | 5 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | 3 | 5 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | 2 | — | — | — | 2 | 4 |
Myofascial pain syndromes | D009209 | EFO_1001054 | — | 1 | — | — | — | 3 | 4 |
Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | 2 | — | — | — | 2 | 4 |
Motor neuron disease | D016472 | EFO_0003782 | G12.2 | 2 | — | — | — | 2 | 4 |
Heart disease risk factors | D000082742 | — | — | 2 | — | — | — | 2 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cognitive dysfunction | D060825 | — | G31.84 | — | — | — | — | 7 | 7 |
Healthy diet | D000072001 | — | — | — | — | — | — | 7 | 7 |
Emergencies | D004630 | — | — | — | — | — | — | 6 | 6 |
Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 6 | 6 |
Chronic disease | D002908 | — | — | — | — | — | — | 5 | 5 |
Hypotrichosis | D007039 | — | — | — | — | — | — | 5 | 5 |
Cerebral palsy | D002547 | — | G80 | — | — | — | — | 4 | 4 |
Respiratory sounds | D012135 | — | R06.1 | — | — | — | — | 4 | 4 |
Crohn disease | D003424 | EFO_0000384 | K50 | — | — | — | — | 4 | 4 |
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 4 | 4 |
Drug common name | Ascorbic acid |
INN | ascorbic acid |
Description | L-ascorbic acid is the L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate. It has a role as a coenzyme, a flour treatment agent, a food antioxidant, a plant metabolite, a cofactor, a skin lightening agent, a geroprotector and a food colour retention agent. It is an ascorbic acid and a vitamin C. It is a conjugate acid of a L-ascorbate. It is an enantiomer of a D-ascorbic acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C1O[C@H]([C@@H](O)CO)C(O)=C1O |
PDB | — |
CAS-ID | 50-81-7 |
RxCUI | — |
ChEMBL ID | CHEMBL196 |
ChEBI ID | 29073 |
PubChem CID | 54670067 |
DrugBank | DB00126 |
UNII ID | PQ6CK8PD0R (ChemIDplus, GSRS) |